Evangelos Giamarellos-Bourboulis
Evangelos Giamarellos-Bourboulis
med.uoa.gr üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Complex immune dysregulation in COVID-19 patients with severe respiratory failure
EJ Giamarellos-Bourboulis, MG Netea, N Rovina, K Akinosoglou, ...
Cell host & microbe 27 (6), 992-1000. e3, 2020
11612020
mTOR-and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity
SC Cheng, J Quintin, RA Cramer, KM Shepardson, S Saeed, V Kumar, ...
Science 345 (6204), 2014
11212014
Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity
S Saeed, J Quintin, HHD Kerstens, NA Rao, A Aghajanirefah, F Matarese, ...
science 345 (6204), 2014
9972014
Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes
J Quintin, S Saeed, JHA Martens, EJ Giamarellos-Bourboulis, DC Ifrim, ...
Cell host & microbe 12 (2), 223-232, 2012
7052012
Azithromycin: mechanisms of action and their relevance for clinical applications
MJ Parnham, VE Haber, EJ Giamarellos-Bourboulis, G Perletti, ...
Pharmacology & therapeutics 143 (2), 225-245, 2014
3972014
Two phase 3 trials of adalimumab for hidradenitis suppurativa
AB Kimball, MM Okun, DA Williams, AB Gottlieb, KA Papp, CC Zouboulis, ...
New England Journal of Medicine 375 (5), 422-434, 2016
3822016
TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans
B Ferwerda, MBB McCall, S Alonso, EJ Giamarellos-Bourboulis, ...
Proceedings of the National Academy of Sciences 104 (42), 16645-16650, 2007
3672007
Carrier systems for the local delivery of antibiotics in bone infections
K Kanellakopoulou, EJ Giamarellos-Bourboulis
Drugs 59 (6), 1223-1232, 2000
3672000
What causes hidradenitis suppurativa?
L Ralf Paus, H Kurzen, I Kurokawa, GBE Jemec, L Emtestam, K Sellheyer, ...
Experimental dermatology 17 (5), 455-456, 2008
3642008
Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis
SC Cheng, BP Scicluna, RJW Arts, MS Gresnigt, E Lachmandas, ...
Nature immunology 17 (4), 406-413, 2016
3222016
A guiding map for inflammation
MG Netea, F Balkwill, M Chonchol, F Cominelli, MY Donath, ...
Nature immunology 18 (8), 826-831, 2017
2912017
Engagement of fatty acids with toll‐like receptor 2 drives interleukin‐1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal–induced gouty arthritis
LAB Joosten, MG Netea, E Mylona, MI Koenders, RKS Malireddi, ...
Arthritis & Rheumatism 62 (11), 3237-3248, 2010
2472010
Benefits of a synbiotic formula (Synbiotic 2000Forte®) in critically ill trauma patients: early results of a randomized controlled trial
K Kotzampassi, EJ Giamarellos-Bourboulis, A Voudouris, P Kazamias, ...
World journal of surgery 30 (10), 1848-1855, 2006
2432006
Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection
MG Netea, EJ Giamarellos-Bourboulis, J Domínguez-Andrés, N Curtis, ...
Cell 181 (5), 969-977, 2020
2342020
Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators
EJ Giamarellos-Bourboulis
International journal of antimicrobial agents 31 (1), 12-20, 2008
2312008
Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?
EJ Giamarellos-Bourboulis, A Mega, P Grecka, N Scarpa, G Koratzanis, ...
Intensive care medicine 28 (9), 1351-1356, 2002
2252002
Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia
EJ Giamarellos-Bourboulis, JC Pechere, C Routsi, D Plachouras, ...
Clinical Infectious Diseases 46 (8), 1157-1164, 2008
2152008
Effect and safety of meropenem–vaborbactam versus best-available therapy in patients with carbapenem-resistant Enterobacteriaceae infections: the TANGO II randomized clinical trial
RG Wunderink, EJ Giamarellos-Bourboulis, G Rahav, AJ Mathers, ...
Infectious diseases and therapy 7 (4), 439-455, 2018
1882018
Dosing guidance for intravenous colistin in critically ill patients
RL Nation, SM Garonzik, V Thamlikitkul, EJ Giamarellos-Bourboulis, ...
Clinical Infectious Diseases 64 (5), 565-571, 2017
1832017
The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome
E Pyleris, EJ Giamarellos-Bourboulis, D Tzivras, V Koussoulas, ...
Digestive diseases and sciences 57 (5), 1321-1329, 2012
1792012
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20